Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-04

FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (SpecGx LLC)

View source ↗

Summary

FDA approved a supplemental application for an oxycodone hydrochloride and acetaminophen product submitted by SpecGx LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXYCODONE AND ACETAMINOPHEN (oxycodone and acetaminophen)

Snippet

SUPPL AP for OXYCODONE AND ACETAMINOPHEN (OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN)